AIT Laboratories Announces Name, Brand Identity for New Division

INDIANAPOLIS, May 18 /PRNewswire/ -- AIT Laboratories, which specializes in
pain management, forensics, and clinical testing, is announcing that its newly
created pharmaceutical testing division will be known as AIT Bioscience, LLC.
Recently, AIT Laboratories announced that the division will be located at its
Indianapolis, Ind. headquarters.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090518/DE18644LOGO )

"AIT Bioscience will operate under the same quality principles that I founded
AIT Laboratories on 19 years ago," said AIT Laboratories President and CEO
Michael A. Evans, Ph.D. "We have some of the industry's most veteran
scientists leading the new division, including Ronald Shoup, Ph.D., who brings
more than 30 years of leadership, entrepreneurship and scientific expertise to
AIT Bioscience." Prior to joining AIT, Dr. Shoup was chief scientific officer
of Bioanalytical Systems, Inc. in West Lafayette, Ind.

"Bioanalytical testing is closely aligned with what AIT Laboratories already
does in terms of processes and equipment. AIT Bioscience wants to take those
resources and apply them to the pharmaceutical industry in ways other CROs
only wish they could," Shoup explained. "Our talent and lack of legacy systems
allow us to build an organization from the ground up that caters to the
client's specific needs. The goal is to work as a partner with drug developers
to coordinate activities throughout the testing process and provide access to
data in real time as it's produced by our laboratory."

The decision to create AIT Bioscience was based on AIT's desire to improve
upon the traditional CRO model. The new company will provide clients the
capability to monitor sample activity from point of collection to the final
report in a completely paperless environment that assures correctness from one
step to the next. Instead of addressing issues after the fact, the company
aims to prevent them with novel electronic systems that reject potential
deviations and errors in real time.

With a newly constructed laboratory in Indianapolis, AIT Bioscience will be
fully operational by the fall of 2009.

Joining Shoup at AIT Bioscience are industry veterans with numerous years of
experience in bioanalytical testing.

-- Timothy P. Grever serves as AIT Bioscience laboratory director. Grever
comes to AIT Bioscience from Bioanalytical Systems, Inc. in West
Lafayette, Ind., where he has held several positions over the past ten
years, the most recent being director of bioanalytical operations
where
he led a 54-member bioanalytical team.
-- Brian D. Beato, Ph.D. serves as senior scientist, mass spectrometry.
Prior to joining AIT Bioscience, Beato served as laboratory and
technical manager for Covance Bioanalytical Services in Indianapolis,
Ind., where he helped start up and expand a bioanalytical LC/MS/MS
laboratory. Beato possesses more than 17 years of experience in
quantitative pharmaceutical analysis and method development, the
majority in bioanalytical LC/MS/MS.

-- Laurel Branstrator will assist AIT Bioscience as director of quality
assurance GxP. She has most recently offered her expertise to the
industry via her consulting firm, LEB Consulting Services. Prior to
her
consulting work, she served as senior director of quality assurance at
Bioanalytical Systems, Inc.

AIT Bioscience partnered with Indianapolis branding firm Miles Design
(www.milesdesign.com) to develop the new brand identity including the logo,
marketing materials and website. Miles Design principal Josh Miles stated,
"Working with AIT's new bioscience venture is very exciting for us -
especially because it's an opportunity to build on a strong relationship with
an existing partner. Internally, we had always hoped to 'find another AIT.' So
when it actually happened, we were thrilled."

About AIT Bioscience:

AIT Bioscience, LLC, headquartered in Indianapolis, Ind., is a bioanalytical
contract research organization supporting pre-clinical, Phase I, II, and III
clinical trials. AIT Bioscience's mission is to create a new standard for
quantitative bioanalytical analysis and drug development in support of small
biotech and large Pharma companies. Learn more about AIT Bioscience at
www.AITBioscience.com.

Contact: Raquel Bahamonde
Executive Director of Corporate Communications
Phone: (317) 243-3894, ext. 476
Cell: (317) 308-0064
E-mail: rbahamonde@aitlabs.com

SOURCE AIT Laboratories

Raquel Bahamonde, Executive Director of Corporate Communications of AIT
Laboratories, +1-317-243-3894, ext. 476, Cell: +1-317-308-0064,
rbahamonde@aitlabs.com